Publication: How can optimal cytoreduction rates increased over ninety percent with a minimal usage of neoadjuvant chemotherapy ?
| dc.contributor.coauthor | Onan, Anıl | |
| dc.contributor.coauthor | Karataş, Funda | |
| dc.contributor.coauthor | Bostancı, Esra | |
| dc.contributor.coauthor | Kerem, Mustafa | |
| dc.contributor.coauthor | Arvas, Macit | |
| dc.contributor.coauthor | Güner, Haldun | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.facultymember | Yes | |
| dc.contributor.kuauthor | Alper, Aydın | |
| dc.contributor.kuauthor | Balık, Emre | |
| dc.contributor.kuauthor | Mısırlıoğlu, Selim | |
| dc.contributor.kuauthor | Taşkıran, Çağatay | |
| dc.contributor.kuauthor | Yıldız, Şule | |
| dc.contributor.schoolcollegeinstitute | SCHOOL OF MEDICINE | |
| dc.date.accessioned | 2024-11-09T23:58:39Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | BAKILACAK | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | WOS | |
| dc.description.openaccess | NO | |
| dc.description.peerreviewstatus | N/A | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.eissn | 1525-1438 | |
| dc.identifier.embargo | N/A | |
| dc.identifier.issn | 1048-891X | |
| dc.identifier.quartile | Q1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/15501 | |
| dc.identifier.wos | 387109100651 | |
| dc.language.iso | eng | |
| dc.publisher | Lippincott Williams and Wilkins (LWW) | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | International Journal of Gynecological Cancer | |
| dc.relation.openaccess | N/A | |
| dc.rights | N/A | |
| dc.subject | Oncology | |
| dc.subject | Obstetrics | |
| dc.subject | Gynecology | |
| dc.title | How can optimal cytoreduction rates increased over ninety percent with a minimal usage of neoadjuvant chemotherapy ? | |
| dc.type | Meeting Abstract | |
| dspace.entity.type | Publication | |
| local.contributor.kuauthor | Taşkıran, Çağatay | |
| local.contributor.kuauthor | Mısırlıoğlu, Selim | |
| local.contributor.kuauthor | Oğuz, Şule Yıldız | |
| local.contributor.kuauthor | Balık, Emre | |
| local.contributor.kuauthor | Alper, Aydın | |
| relation.isOrgUnitOfPublication | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isOrgUnitOfPublication.latestForDiscovery | d02929e1-2a70-44f0-ae17-7819f587bedd | |
| relation.isParentOrgUnitOfPublication | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 17f2dc8e-6e54-4fa8-b5e0-d6415123a93e |
